Redo-TAVI with a supra-annular large-cell ACURATE valve for failed short-frame THVs offers potential haemodynamic & coronary access advantages. This initial clinical experience highlights key pre- and procedural considerations to optimise outcomes shorturl.at/pHSoe #TAVI #cardiosky #Eurointervention